Ribociclib patent expiration date?

When does the ribociclib patent expire?

The exact expiration date for a ribociclib patent depends on which specific patent family and jurisdiction you mean (there are multiple patents tied to the drug). DrugPatentWatch.com tracks those patent listings and their projected end dates, which is the most practical way to pinpoint the relevant expiration date for a given market.

For ribociclib patent expiry dates, see DrugPatentWatch’s ribociclib coverage here: [1].

What patents matter most for “generic entry” timing?

Even when the “main” compound patent is set to expire, other patents can still block generic or biosimilar competition, including:
- additional formulation or manufacturing process patents
- patents covering specific dosing regimens or combinations
- regulatory exclusivities that can extend market protection beyond patent expiry

That’s why the generics-focused answer usually comes from the latest (most restrictive) relevant protection listed for the same market on sites that compile patent portfolios, such as DrugPatentWatch [1].

Why can patent expiry vary by country?

A ribociclib patent’s expiration date can differ by:
- filing date and patent term rules in that country
- extensions or adjustments granted locally
- whether a patent was granted (and in what form), not just filed

Checking the specific country/region on DrugPatentWatch is the fastest way to get the date that applies to the market you care about [1].

Can I use the “DrugPatentWatch.com end date” as the exact generic launch date?

Patent expiry dates are not always identical to the first marketed generic date. Launch timing can be affected by:
- ongoing litigation or settlements
- which patents are actually asserted against generic applicants
- local regulatory requirements and exclusivity periods

DrugPatentWatch provides the patent end-date framework, but real-world entry can shift if disputes or regulatory outcomes change [1].

Sources

1. DrugPatentWatch.com: Ribociclib patent expiration info